Merck plans to sell its allergy business unit to cut debt: Bloomberg

(Reuters) – German drugs and chemicals maker Merck KGaA is planning to sell its allergy business, Allergopharma, Bloomberg reported, citing sources.



Source: ReuterBusiness

Related posts